BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36773531)

  • 1. Amide proton transfer (APT) imaging of breast cancers and its correlation with biological status.
    Kamitani T; Sagiyama K; Yamasaki Y; Hino T; Wada T; Kubo M; Akiyoshi S; Yamamoto H; Yabuuchi H; Ishigami K
    Clin Imaging; 2023 Apr; 96():38-43. PubMed ID: 36773531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
    Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
    J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
    Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
    Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Amide Proton Transfer Imaging at 3 T: Diagnostic Performance and Association With Pathologic Characteristics.
    Liu Z; Wen J; Wang M; Ren Y; Yang Q; Qian L; Luo H; Feng S; He C; Liu X; Wu Y; Luo D
    J Magn Reson Imaging; 2023 Mar; 57(3):824-833. PubMed ID: 35816177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
    Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
    Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using
    Li B; Sun H; Zhang S; Wang X; Guo Q
    J Magn Reson Imaging; 2019 Jul; 50(1):261-268. PubMed ID: 30430677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Saturation Pulse Duration and Power on pH-weighted Amide Proton Transfer Imaging: A Phantom Study.
    Tokunaga C; Wada T; Togao O; Yamashita Y; Kobayashi K; Kato T
    Magn Reson Med Sci; 2023 Oct; 22(4):487-495. PubMed ID: 36047248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Tsurumaru D; Togao O; Sagiyama K; Manabe T; Oki E; Kubo Y; Hida T; Hirahashi-Fujiwara M; Keupp J; Honda H
    J Gastroenterol Hepatol; 2019 Jan; 34(1):140-146. PubMed ID: 29900583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.
    Dula AN; Arlinghaus LR; Dortch RD; Dewey BE; Whisenant JG; Ayers GD; Yankeelov TE; Smith SA
    Magn Reson Med; 2013 Jul; 70(1):216-24. PubMed ID: 22907893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging can predict tumor grade in rectal cancer.
    Nishie A; Takayama Y; Asayama Y; Ishigami K; Ushijima Y; Okamoto D; Fujita N; Tsurumaru D; Togao O; Manabe T; Oki E; Kubo Y; Hida T; Hirahashi-Fujiwara M; Keupp J; Honda H
    Magn Reson Imaging; 2018 Sep; 51():96-103. PubMed ID: 29729438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide proton transfer (APT) imaging of parotid tumors: Differentiation of malignant and benign tumors.
    Kamitani T; Sagiyama K; Togao O; Yamasaki Y; Hida T; Matsuura Y; Murayama Y; Yasumatsu R; Yamamoto H; Yabuuchi H
    Eur J Radiol; 2020 Aug; 129():109047. PubMed ID: 32460200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores.
    Takayama Y; Nishie A; Sugimoto M; Togao O; Asayama Y; Ishigami K; Ushijima Y; Okamoto D; Fujita N; Yokomizo A; Keupp J; Honda H
    MAGMA; 2016 Aug; 29(4):671-9. PubMed ID: 26965511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.